Qfitlia Side Effects
Generic name: fitusiran
Note: This document provides detailed information about Qfitlia.
Applies to fitusiran: subcutaneous solution.
General adverse events
The most common adverse reactions in patients treated with the antithrombin-based dose regimen were viral infection, nasopharyngitis, and bacterial infection Side Effects associated with fitusiran. Some dosage forms listed on this page may not apply specifically to the brand name Qfitlia.
Applies to fitusiran: subcutaneous solution.
General adverse events
The most common adverse reactions in patients treated with the antithrombin-based dose regimen were viral infection, nasopharyngitis, and bacterial infection.
Refer to the manufacturer product information for detailed descriptions of adverse reactions and/or for definitions of included terms.[Ref]
Cardiovascular
- Common (1% to 10%): Serious thrombotic events
- Frequency not reported: Cerebral venous sinus thrombosis, post-operative deep vein thrombosis
Dermatologic
- Frequency not reported: Pruritus
Gastrointestinal
- Common (1% to 10%): Acute or recurrent gallbladder disease, including cholelithiasis and cholecystitis
- Frequency not reported: Dyspepsia, abdominal pain
Hematologic
- Common (1% to 10%): Prothrombin fragment 1.2 increased
Hepatic
- Common (1% to 10%): Hepatic/liver injury, including increased ALT/AST
Immunologic
- Common (1% to 10%): Antidrug antibodies
Local
- Common (1% to 10%): Injection site reaction
Adverse effects at the injection site included bruising, erythema, pain, hematoma, atrophy, hemorrhage, discomfort, swelling, discoloration, pruritus, induration, nodule, mass, vesicles, deformation, rash, and joint pain.
Musculoskeletal
- Common (1% to 10%): Arthralgia
Nervous system
- Common (1% to 10%): Headache
- Frequency not reported: Cerebral infarction
Other
- Very common (10% or more): Viral infection (29%), bacterial infection (11%)
Respiratory
- Very common (10% or more): Nasopharyngitis (26%)
- Common (1% to 10%): Cough
References
1. (2025) "Product Information. Qfitlia (fitusiran)." Genzyme Corporation
More about Qfitlia (fitusiran)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
Professional resources
Related treatment guides
Further information
Qfitlia side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.